Gateway Investment Advisers’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-29,056
Closed -$5.15M 539
2020
Q1
$5.15M Buy
29,056
+7,882
+37% +$1.48M 0.06% 214
2019
Q4
$4.05M Sell
21,174
-837
-4% -$151K 0.04% 278
2019
Q3
$3.7M Sell
22,011
-10,352
-32% -$1.69M 0.04% 303
2019
Q2
$5.42M Sell
32,363
-810
-2% -$112K 0.05% 255
2019
Q1
$4.86M Sell
33,173
-9,915
-23% -$1.44M 0.04% 273
2018
Q4
$5.76M Sell
43,088
-182,443
-81% -$29.9M 0.05% 252
2018
Q3
$43M Sell
225,531
-404
-0.2% -$74.2K 0.36% 78
2018
Q2
$37.7M Sell
225,935
-1,916
-0.8% -$308K 0.33% 82
2018
Q1
$38.3M Sell
227,851
-7,345
-3% -$1.23M 0.34% 82
2017
Q4
$38.5M Sell
235,196
-1,344
-0.6% -$241K 0.33% 84
2017
Q3
$48.5M Sell
236,540
-12,408
-5% -$2.89M 0.42% 69
2017
Q2
$60.5M Buy
248,948
+75
+0% +$17.6K 0.54% 49
2017
Q1
$59.5M Sell
248,873
-4,663
-2% -$1.09M 0.55% 48
2016
Q4
$53.2M Buy
253,536
+5,062
+2% +$1.05M 0.5% 57
2016
Q3
$57.2M Buy
248,474
+1,667
+0.7% +$407K 0.51% 56
2016
Q2
$57M Sell
246,807
-9,826
-4% -$2.27M 0.49% 58
2016
Q1
$68.8M Sell
256,633
-10,700
-4% -$3.06M 0.6% 49
2015
Q4
$83.5M Sell
267,333
-372
-0.1% -$111K 0.7% 40
2015
Q3
$72.8M Sell
267,705
-526
-0.2% -$162K 0.65% 45
2015
Q2
$81.4M Buy
268,231
+2,113
+0.8% +$630K 0.68% 42
2015
Q1
$79.2M Buy
266,118
+68,177
+34% +$19.4M 0.66% 44
2014
Q4
$51M Buy
197,941
+161,278
+440% +$40.3M 0.42% 72
2014
Q3
$8.85M Buy
36,663
+15,407
+72% +$3.45M 0.07% 222
2014
Q2
$4.74M Buy
21,256
+3,258
+18% +$675K 0.04% 294
2014
Q1
$3.71M Sell
17,998
-379
-2% -$75.1K 0.03% 313
2013
Q4
$3.09M Buy
18,377
+4,590
+33% +$718K 0.02% 335
2013
Q3
$1.99M Buy
13,787
+1,083
+9% +$144K 0.02% 394
2013
Q2
$1.6M Buy
+12,704
New +$1.44M 0.01% 409

Other funds holding AGN

Gateway Investment Advisers's AGN Position: Q2 2020 in Review

Gateway Investment Advisers sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 29,056 shares — an estimated $5.15M sold.

Gateway Investment Advisers first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $83.5M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Gateway Investment Advisers reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Gateway Investment Advisers sold 29,056 Allergan plc shares in Q2 2020, an estimated $5.15M.
  • Gateway Investment Advisers first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Gateway Investment Advisers's Allergan plc position peaked at $83.5M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Gateway Investment Advisers's 13F filing for Q2 2020, filed 15 Jul 2020.